endocrine/exocrine glands
• large lymphoid aggregates surround but do not penetrate many islets
|
Allele Symbol Allele Name Allele ID |
Il3tm1Glli targeted mutation 1, Stephen J Galli MGI:2446538 |
||||||||||||||||||||||||||||||||||||
Summary |
8 genotypes
|
|
|
♀ | phenotype observed in females |
♂ | phenotype observed in males |
N | normal phenotype |
• large lymphoid aggregates surround but do not penetrate many islets
|
|
|
♀ | phenotype observed in females |
♂ | phenotype observed in males |
N | normal phenotype |
• decreased induction of mast cells in bone marrow
• decreased mast cell hyperplasia in intestine, effect in jejunum less significant in BALB/c than C57BL/6 background
|
• less intense cellular infiltrates
• less edema
• fewer and smaller intraepidermal abscesses
|
• delayed expulsion of parasites - Strongyloides venezuelensis
• parasites fail to induce increases in basophils
|
• decreased induction of mast cells in bone marrow
• decreased mast cell hyperplasia in intestine, effect in jejunum less significant in BALB/c than C57BL/6 background
|
• decreased induction of mast cells in bone marrow
• decreased mast cell hyperplasia in intestine, effect in jejunum less significant in BALB/c than C57BL/6 background
|
|
|
♀ | phenotype observed in females |
♂ | phenotype observed in males |
N | normal phenotype |
• islet adenomas
|
N |
• significantly reduced fasting blood sugar, to levels similar to controls
• improved glucose tolerance
|
• islet adenomas
|
• islet adenomas
|
|
|
♀ | phenotype observed in females |
♂ | phenotype observed in males |
N | normal phenotype |
• increase in circulating eosinophiles but not in bone marrow
|
• defective phagocytosis of apoptotic cells
|
• dramatically reduced response to secondary challenge in tests for contact hypersensitivity
• very reduced cellular infiltrates
• much reduced edema
• very little keratinocyte activation
|
• increased level of anti double stranded DNA
|
• appears after 8 months of age
• B and T cell aggregates in the renal pelvis and liver
|
• extensive lymphoid hyperplasia around both airways and veins
|
• extensive lymphoid hyperplasia around both airways and veins
|
• accumulation of surfactant in intra-alveolar spaces
|
• appears after 8 months of age
• B and T cell aggregates in the renal pelvis and liver
|
• increase in circulating eosinophiles but not in bone marrow
|
• defective phagocytosis of apoptotic cells
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
systemic lupus erythematosus | DOID:9074 |
OMIM:152700 OMIM:300809 OMIM:605480 OMIM:608437 OMIM:609903 OMIM:609939 OMIM:610065 OMIM:610066 OMIM:612254 OMIM:612378 OMIM:613145 OMIM:614420 |
J:83086 |
|
|
♀ | phenotype observed in females |
♂ | phenotype observed in males |
N | normal phenotype |
• large lymphoid aggregates surround and penetrate many islets
• islets are reduced in size
|
• reduced number of insulin secreting beta cells
|
• fasting hyperglycemia in most but not all 8 month old mice
• significantly increased peak blood sugar after glucose challenge
|
• significantly increased peak blood sugar after glucose challenge
|
|
|
♀ | phenotype observed in females |
♂ | phenotype observed in males |
N | normal phenotype |
• increase in circulating eosinophiles but not in bone marrow
|
• dramatically reduced response to secondary challenge in tests for contact hypersensitivity
• very reduced cellular infiltrates
• much reduced edema
• very little keratinocyte activation
|
• accumulation of surfactant in intra-alveolar spaces
• extensive lymphoid hyperplasia around both airways and veins
|
• accumulation of surfactant in intra-alveolar spaces
• extensive lymphoid hyperplasia around both airways and veins
|
• accumulation of surfactant in intra-alveolar spaces
|
• increase in circulating eosinophiles but not in bone marrow
|
|
|
♀ | phenotype observed in females |
♂ | phenotype observed in males |
N | normal phenotype |
• surviving mice became moribund with time
• most died or had to be euthanized before 14 months of age
|
• about 40% of homozygotes died of pneumonia in the first few weeks of life
|
• mild eosinophilia in mice surviving beyond the first few weeks of life
|
• serum levels increased but not significantly
|
• significantly higher serum IgG1 levels
• non significant increases in serum IgG2b levels
|
• acute and chronic inflammatory reactions found in many organs and tissues
|
• Lymphoproliferative disease in a high proportion of mice
• develops into B cell lymphomas
|
• solid tumors are benign to metastasizing carcinomas
|
• particularly prevalent
|
• mild eosinophilia in mice surviving beyond the first few weeks of life
|
• serum levels increased but not significantly
|
• significantly higher serum IgG1 levels
• non significant increases in serum IgG2b levels
|
• particularly prevalent
|
• particularly prevalent
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
NOT | systemic lupus erythematosus | DOID:9074 |
OMIM:152700 OMIM:300809 OMIM:605480 OMIM:608437 OMIM:609903 OMIM:609939 OMIM:610065 OMIM:610066 OMIM:612254 OMIM:612378 OMIM:613145 OMIM:614420 |
J:83086 |
|
|
♀ | phenotype observed in females |
♂ | phenotype observed in males |
N | normal phenotype |
• particularly significant delay in expulsion of parasites - Strongyloides venezuelensis
|
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 11/12/2024 MGI 6.24 |
|
|